Bellerophon Therapeutics (BLPH) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts BLPH Hot Sheet
Join SI Premium – FREE
Bellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.53), $0.06 better than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs
- Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
